Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Blumenthal

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Anticancer Research|February 26, 2004
Tumor-specific dose scheduling of bimodal radioimmunotherapy and chemotherapyR D Blumenthal, E Leone, D M Goldenberg
Seminars in Cancer Biology|June 1, 1990
Biological and clinical perspectives of cancer imaging and therapy with radiolabeled antibodiesD M Goldenberg, R D Blumenthal, R M Sharkey
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1993
Radiolabeled antibodies as cancer therapeuticsR M Sharkey, R D Blumenthal, D M Goldenberg
Cancer Treatment and Research|January 1, 1990
Experimental model systems for antibody targeting and radioimmunodetectionR D Blumenthal, R M Sharkey, D M Goldenberg
Cancer Treatment and Research|January 1, 1990
Anti-antibody enhancement of tumor imagingR M Sharkey, R D Blumenthal, D M Goldenberg
Journal of the National Cancer Institute|March 18, 1992
Dose escalation of radioantibody in a mouse model with the use of recombinant human interleukin-1 and granulocyte-macrophage colony-stimulating factor intervention to reduce myelosuppressionR D Blumenthal, R M Sharkey, D M Goldenberg
British Journal of Cancer|August 30, 2008
In vitro and in vivo anticancer efficacy of unconjugated humanized anti-CEA monoclonal antibodiesR D Blumenthal, H J Hansen, D M Goldenberg
Expert Reviews in Molecular Medicine|October 31, 2003
Unique molecular markers in human endometriosis: implications for diagnosis and therapyR D Blumenthal, A Taylor, M Samoszuk, et al.
International Journal of Cancer|May 16, 1995
Quantitative and qualitative effects of experimental radioimmunotherapy on tumor vascular permeabilityR D Blumenthal, R Kashi, R M Sharkey, et al.
International Journal of Cancer|August 15, 1989
Comparison of therapeutic efficacy and host toxicity of two different 131I-labelled antibodies and their fragments in the GW-39 colonic cancer xenograft modelR D Blumenthal, R M Sharkey, R Kashi, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Anticancer Research|February 26, 2004
Tumor-specific dose scheduling of bimodal radioimmunotherapy and chemotherapyR D Blumenthal, E Leone, D M Goldenberg
Seminars in Cancer Biology|June 1, 1990
Biological and clinical perspectives of cancer imaging and therapy with radiolabeled antibodiesD M Goldenberg, R D Blumenthal, R M Sharkey
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1993
Radiolabeled antibodies as cancer therapeuticsR M Sharkey, R D Blumenthal, D M Goldenberg
Cancer Treatment and Research|January 1, 1990
Experimental model systems for antibody targeting and radioimmunodetectionR D Blumenthal, R M Sharkey, D M Goldenberg
Cancer Treatment and Research|January 1, 1990
Anti-antibody enhancement of tumor imagingR M Sharkey, R D Blumenthal, D M Goldenberg
Journal of the National Cancer Institute|March 18, 1992
Dose escalation of radioantibody in a mouse model with the use of recombinant human interleukin-1 and granulocyte-macrophage colony-stimulating factor intervention to reduce myelosuppressionR D Blumenthal, R M Sharkey, D M Goldenberg
British Journal of Cancer|August 30, 2008
In vitro and in vivo anticancer efficacy of unconjugated humanized anti-CEA monoclonal antibodiesR D Blumenthal, H J Hansen, D M Goldenberg
Expert Reviews in Molecular Medicine|October 31, 2003
Unique molecular markers in human endometriosis: implications for diagnosis and therapyR D Blumenthal, A Taylor, M Samoszuk, et al.
International Journal of Cancer|May 16, 1995
Quantitative and qualitative effects of experimental radioimmunotherapy on tumor vascular permeabilityR D Blumenthal, R Kashi, R M Sharkey, et al.
International Journal of Cancer|August 15, 1989
Comparison of therapeutic efficacy and host toxicity of two different 131I-labelled antibodies and their fragments in the GW-39 colonic cancer xenograft modelR D Blumenthal, R M Sharkey, R Kashi, et al.
Pageof 6